207 related articles for article (PubMed ID: 32522162)
1. Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report.
Glover EK; Speight RA; Televantou D; Needham S; Sheerin NS
BMC Nephrol; 2020 Jun; 21(1):220. PubMed ID: 32522162
[TBL] [Abstract][Full Text] [Related]
2. Acute renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
Purighalla R; Shapiro R; Jordan ML; Scantlebury VP; Gritsch HA; Vivas C; Randhawa PS
Clin Transplant; 1997 Dec; 11(6):574-6. PubMed ID: 9408687
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
Köpf S; Tönshoff B
Pediatr Nephrol; 2004 Apr; 19(4):365-8. PubMed ID: 14963763
[TBL] [Abstract][Full Text] [Related]
4. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
Srivastava T; Zwick DL; Rothberg PG; Warady BA
Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin's lymphoma after post-transplant lymphoproliferative disease in a renal transplant recipient.
Dharnidharka VR; Douglas VK; Hunger SP; Fennell RS
Pediatr Transplant; 2004 Feb; 8(1):87-90. PubMed ID: 15009846
[TBL] [Abstract][Full Text] [Related]
6. Posttransplantation lymphoproliferative disorder in a renal allograft recipient.
Goral S; Felgar R; Shappell S
Am J Kidney Dis; 1997 Aug; 30(2):301-7. PubMed ID: 9261047
[TBL] [Abstract][Full Text] [Related]
7. Cessation of immunosuppression during chemotherapy for post-transplant lymphoproliferative disorders in renal transplant patients.
Taylor E; Jones M; Hourigan MJ; Johnson DW; Gill DS; Isbel N; Hawley CM; Marlton P; Gandhi MK; Campbell SB; Mollee P
Nephrol Dial Transplant; 2015 Oct; 30(10):1774-9. PubMed ID: 26188340
[TBL] [Abstract][Full Text] [Related]
8. Post-transplant Lymphoproliferative Disorder in a Patient After Kidney Transplant, 5-Year Follow-up: A Case Report.
Ignacak E; Sułowicz J; Giza A; Cieniawski D; Kuźniewski M; Sułowicz W
Transplant Proc; 2020 Oct; 52(8):2517-2519. PubMed ID: 32222386
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
Patil R; Prashar R; Patel A
Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
[TBL] [Abstract][Full Text] [Related]
10. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
Ranganathan S; Webber S; Ahuja S; Jaffe R
Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
[TBL] [Abstract][Full Text] [Related]
12. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
Chen DB; Wang Y; Song QJ; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
Wasson S; Zafar MN; Best J; Reddy HK
J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant lymphoproliferative disorders (PTLD) after renal transplantation: management and evolution of seven cases among 1002 renal transplants in São Paulo, Brazil.
Colleoni GW; Oliveira JS; Borducchi DM; Fernandes MA; Da Silva HT; Alves AC; De Franco MF; Kerbauy J; Pestana JO
Leuk Lymphoma; 2000 Sep; 39(1-2):145-50. PubMed ID: 10975393
[TBL] [Abstract][Full Text] [Related]
15. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ
Transpl Int; 2007 Mar; 20(3):207-18. PubMed ID: 17291214
[TBL] [Abstract][Full Text] [Related]
16. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
[TBL] [Abstract][Full Text] [Related]
17. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
[TBL] [Abstract][Full Text] [Related]
18. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for PTLD diagnosis and therapies.
Martinez OM
Pediatr Nephrol; 2020 Jul; 35(7):1173-1181. PubMed ID: 31240394
[TBL] [Abstract][Full Text] [Related]
20. Post-transplant lymphoproliferative disease.
Dharnidharka VR; Araya CE
Pediatr Nephrol; 2009 Apr; 24(4):731-6. PubMed ID: 17891420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]